GSK: COMMITMENT YOU CAN COUNT ON

Service. Value. Relationship.

GSK: COMMITMENT
YOU CAN COUNT ON

Commitment Hero Image

 

Indication for PEDIARIX

PEDIARIX is indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. PEDIARIX is approved for use as a 3-dose series in infants born of
hepatitis B surface antigen (HBsAg)-negative mothers. PEDIARIX may be given as early as 6 weeks of age through 6 years of age (prior to the 7th birthday).

 

Bottle

Why choose PEDIARIX?

SCHEDULE FLEXIBILITY 

PEDIARIX has the broadest age indication among combination DTaP vaccines—as early as 6 weeks of age up until the 7th birthday.1,3,4

SAVINGS 

Programs and memberships designed to give you maximum portfolio discounts, GSK’s best private pricing, and other contract benefits.

SUPPLY RELIABILITY 

Learn about the history of DTaP vaccine supply and the role PEDIARIX played.

PERTUSSIS IS ACTIVE IN THE UNITED STATES5,6

See the data on this serious, highly contagious disease.5,6

 

DID YOU KNOW? 

PEDIARIX is available in color-coded, single-dose, prefilled syringes to help with easy and quick identification.1

 

DTaP=diphtheria, tetanus, and acellular pertussis.

DTaP=diphtheria, tetanus, and acellular pertussis.